Rupa Ray, Ph.D. - Publications

Affiliations: 
2007 Duke University, Durham, NC 
Area:
Pharmacology, Parasitology Biology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Gonzalez-Gronow M, Fiedler JL, Farias Gomez C, Wang F, Ray R, Ferrell PD, Pizzo SV. Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent l-lysine-containing domains. Biochemical and Biophysical Research Communications. PMID 28648598 DOI: 10.1016/J.Bbrc.2017.06.131  0.368
2015 Gonzalez-Gronow M, Cuchacovich M, Francos R, Cuchacovich S, Blanco A, Sandoval R, Gomez CF, Valenzuela JA, Ray R, Pizzo SV. Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus. Journal of Neuroimmunology. 287: 1-8. PMID 26439953 DOI: 10.1016/J.Jneuroim.2015.07.006  0.301
2014 Gonzalez-Gronow M, Gomez CF, de Ridder GG, Ray R, Pizzo SV. Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro. The Journal of Biological Chemistry. 289: 25166-76. PMID 25059665 DOI: 10.1074/Jbc.M114.589341  0.408
2013 Gonzalez-Gronow M, Ray R, Wang F, Pizzo SV. The voltage-dependent anion channel (VDAC) binds tissue-type plasminogen activator and promotes activation of plasminogen on the cell surface. The Journal of Biological Chemistry. 288: 498-509. PMID 23161549 DOI: 10.1074/Jbc.M112.412502  0.376
2013 Ridder GGd, Ray R, Pizzo SV. Abstract 5248: Tunneling nanotubes connect melanoma cells and mediate transfer of mitochondria and GRP78. Cancer Research. 73: 5248-5248. DOI: 10.1158/1538-7445.Am2013-5248  0.378
2013 Ray R, Ridder Gd, Pizzo SV. Abstract 1247: Development of GRP78 scFv-Subtilase fusion proteins for sensitization of melanoma to chemotherapeutics. Cancer Research. 73: 1247-1247. DOI: 10.1158/1538-7445.Am2013-1247  0.435
2012 Ray R, de Ridder GG, Eu JP, Paton AW, Paton JC, Pizzo SV. The Escherichia coli subtilase cytotoxin A subunit specifically cleaves cell-surface GRP78 protein and abolishes COOH-terminal-dependent signaling. The Journal of Biological Chemistry. 287: 32755-69. PMID 22851173 DOI: 10.1074/Jbc.M112.399808  0.335
2012 de Ridder GG, Ray R, Pizzo SV. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice. Melanoma Research. 22: 225-35. PMID 22495669 DOI: 10.1097/Cmr.0B013E32835312Fd  0.321
2011 de Ridder G, Ray R, Misra UK, Pizzo SV. Modulation of the unfolded protein response by GRP78 in prostate cancer. Methods in Enzymology. 489: 245-57. PMID 21266234 DOI: 10.1016/B978-0-12-385116-1.00014-5  0.41
2011 de Ridder GG, Gonzalez-Gronow M, Ray R, Pizzo SV. Autoantibodies against cell surface GRP78 promote tumor growth in a murine model of melanoma. Melanoma Research. 21: 35-43. PMID 21164368 DOI: 10.1097/Cmr.0B013E3283426805  0.309
2003 Ray R, Haystead TA. Phosphoproteome analysis in yeast. Methods in Enzymology. 366: 95-103. PMID 14674242 DOI: 10.1016/S0076-6879(03)66008-8  0.57
2003 Ray R, Haystead TA. Mixed peptide sequencing and the FASTF/FASTS algorithms. Methods in Enzymology. 366: 84-95. PMID 14674241 DOI: 10.1016/S0076-6879(03)66007-6  0.544
2002 Graves PR, Kwiek JJ, Fadden P, Ray R, Hardeman K, Coley AM, Foley M, Haystead TA. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Molecular Pharmacology. 62: 1364-72. PMID 12435804 DOI: 10.1124/Mol.62.6.1364  0.344
Show low-probability matches.